Latest Foresite Capital Management IV, LLC Stock Portfolio
$197Million
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Foresite Capital Management IV, LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Foresite Capital Management IV, LLC reported an equity portfolio of $197.9 Millions as of 31 Mar, 2024.
The top stock holdings of Foresite Capital Management IV, LLC are PHVS, KURA, KNTE. The fund has invested 47.2% of it's portfolio in PHARVARIS N.V. and 19.9% of portfolio in KURA ONCOLOGY, INC.
The top stock holdings of Foresite Capital Management IV, LLC are PHVS, KURA, KNTE. The fund has invested 47.2% of it's portfolio in PHARVARIS N.V. and 19.9% of portfolio in KURA ONCOLOGY, INC.
New Buys
Additions
Reductions
Sold off
Current Stock Holdings of Foresite Capital Management IV, LLC
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| KNTE | KINNATE BIOPHARMA INC. | 13.00 | 9,671,640 | 25,726,600 | UNCHANGED | 0.00 | |
| KURA | KURA ONCOLOGY, INC. | 19.94 | 1,849,950 | 39,459,400 | UNCHANGED | 0.00 | |
| LYEL | LYELL IMMUNOPHARMA, INC. | 9.38 | 8,325,000 | 18,564,800 | UNCHANGED | 0.00 | |
| PHVS | PHARVARIS N.V. | 47.16 | 4,038,840 | 93,337,600 | UNCHANGED | 0.00 | |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 10.52 | 875,000 | 20,825,000 | UNCHANGED | 0.00 |